| Descriptor English: | Pyrazinamide | ||||
| Descriptor Spanish: |
Pirazinamida
| ||||
| Descriptor Portuguese: | Pirazinamida | ||||
| Descriptor French: | Pyrazinamide | ||||
| Entry term(s): |
Tisamid |
||||
| Tree number(s): |
D03.383.679.750 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D011718 | ||||
| Scope note: | A pyrazine that is used therapeutically as an antitubercular agent. |
||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
| Pharm Action: |
Antitubercular Agents |
||||
| Registry Number: | 2KNI5N06TI | ||||
| CAS Type 1 Name: | Pyrazinecarboxamide | ||||
| DeCS ID: | 12154 | ||||
| Unique ID: | D011718 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 1966/01/01 | ||||
| Date of Entry: | 1999/01/01 | ||||
| Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Pyrazinamide
- Preferred
Tisamid
- Narrower
| Concept UI |
M0018224 |
| Scope note | A pyrazine that is used therapeutically as an antitubercular agent. |
| Preferred term | Pyrazinamide |
| Concept UI |
M0373204 |
| Preferred term | Tisamid |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey